Blastomyces Antigen Quantitative

Overview

  • EPIC Code:
  • IMO176
  • Soft Test Code:
  • BDAGS
  • Send Out Test Code:
  • 316
Alternate Names
  • Blastomyces Dermatitidis Antigen
  • Blastomyces Quantitative
  • Blastomyces Quantitative EIA Test
Clinical Significance

The MVista® Blastomyces Antigen Quantitative EIA can detect and quantify the amount of Blastomyces antigen in patient samples. It can be used to aid in the diagnosis of blastomycosis, to monitor the response to therapy and to determine when treatment can be modified or stopped. Monitoring of Blastomyces antigen levels also helps determine relapse of disease.

During validation testing, the sensitivity was found to be 95.00% and specificity 100% with an assay cutoff of 0.31 ng/mL.


Specimen Collection & Preparation

Specimen Requirements:

-OR-

2.0 mL Serum from a SST Gold Top Tube 
Minimum Volume:
1.2 mL Serum*

* This volume does not allow for repeat testing

Processing Instructions:

Allow blood to clot for 30 minutes

Centrifuge and separate serum from cells 


Rejection Criteria:

If specimen is too viscous to pipette

Stored in Transport Media, Fixative or Isolator Tubes

Tissue, Sputum, Bronchial Brushings, Stool, FNA, Biopsy, Tracheal or Bone Marrow Aspirate


Transport and Storage:
  • Ambient: 14 Days
  • Refrigerated: 14 Days
  • Frozen (-20 C or colder): Indefinite

-OR-

2.0 mL Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
Minimum Volume:
1.2 mL Plasma*

* This volume does not allow for repeat testing

Processing Instructions:

Centrifuge specimen for 15 minutes and pipette into a plastic vial

Identify specimen as plasma on container


Rejection Criteria:

If specimen is too viscous to pipette

Stored in Transport Media, Fixative or Isolator Tubes

Tissue, Sputum, Bronchial Brushings, Stool, FNA, Biopsy, Tracheal or Bone Marrow Aspirate


Transport and Storage:
  • Ambient: 14 Days
  • Refrigerated: 14 Days
  • Frozen (-20 C or colder): Indefinitely

Clinical Interpretation

Reference Range:

Negative

0.31 ng/mL – 20.00 ng/mL

Results above 20.00 ng/mL are reported as ‘Positive, Above the Limit of Quantification’


Test Comments:

Negative: <0.31 ng/mL

Positive: ≥0.31 ng/mL – 20.00 ng/mL

Positive Above the Limit of Quantifications
Results greater than 20.00 ng/mL fall outside the linear range of the assay. These results are positive, but not accurately quantifiable.

Results should be correlated with clinical presentation and history.

New positives may require confirmation


Methodology:
  • Quantitative Sandwich Enzyme Immunoassay (EIA)

Clinical Significance

The MVista® Blastomyces Antigen Quantitative EIA can detect and quantify the amount of Blastomyces antigen in patient samples. It can be used to aid in the diagnosis of blastomycosis, to monitor the response to therapy and to determine when treatment can be modified or stopped. Monitoring of Blastomyces antigen levels also helps determine relapse of disease.

During validation testing, the sensitivity was found to be 95.00% and specificity 100% with an assay cutoff of 0.31 ng/mL.


Documentation

It is possible that specimens positive for Candida tropicalis, Coccidioides immitis, Coccidioides posadasii, Histoplasma capsulatum, Histoplasma duboisii, Paracoccidioides brasiliensis, Talaromyces marneffei and Aspergillus nidulans may cross-react with the Blastomyces Antigen EIA and test positive.

A variety of interfering substances, as follows, were investigated for each specimen type and none affected the Blastomyces Antigen EIA sensitivity or specificity.

Urine: glucose, protein, microalbumin, creatine, uric acid, BUN, bilirubin, nitrite, ketones, WBCs, blood/ hemoglobin, antihistamine, ascorbic acid, cough syrup, boric acid, ethyl paraben

Serum: protein, bilirubin, cholesterol, triglycerides, hemoglobin

CSF: protein, blood BAL: blood

Plasma: protein, bilirubin, cholesterol, triglycerides, hemoglobin, lithium heparin, sodium citrate


Production Schedule

Sites Performed
  • MiraVista
Days Performed
Monday
Tuesday
Wednesday
Thursday
Friday
Departments
  • Sendouts - Clinical
Turn Around Time

1 to 2 Days


Coding & Compliance

CDM

00911089


CPT Coding

87449